Literature DB >> 32079441

Methane attenuates lung ischemia-reperfusion injury via regulating PI3K-AKT-NFκB signaling pathway.

Fang Wang1, Feidi Wang2, Fengtao Li1, Dong Wang1, Haopeng Li1, Xijing He1, Jingyao Zhang3.   

Abstract

Objective: This study aims to investigate the protective effects and possible mechanism of methane-rich saline (MS) on lung ischemia-reperfusion injury (LIRI) in rats.
Methods: MS (2 ml/kg and 20 ml/kg) was injected intraperitoneally in rats after LIRI. Lung injury was assayed by Hematoxylin-eosin (HE) staining and wet-to-dry weight (W/D). The cells in the bronchoalveolar lavage fluid (BALF) and blood were counted. Oxidative stress was examined by the level of malondialdehyde (MDA) and superoxide dismutase (SOD). Inflammatory factors including tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and interleukin-10 (IL-10) were determined by ELISA. Lung tissue apoptosis was detected by TUNEL staining and western blotting of Bcl-2, Bax, and caspase-3. The expressions of IкBα, p38, PI3K, AKT, and NF-κB were analyzed with Western blotting.
Results: MS effectively decreased the lung W/D ratio as well as the lung pathological damage and reduced the localized infiltration of inflammatory cells. Methane suppressed the expression of the PI3K-AKT-NFκB signaling pathway during the lung IR injury, which inhibited the activation of NF-kB and decreased the level of inflammatory cytokines, such as TNF-α, IL-1β, and IL-10. Moreover, we found that MS treatment relieved reactive oxygen species (ROS) damage by downregulating MDA and upregulating SOD. MS treatment also regulated apoptosis-related proteins, such as Bcl-2, Bax, and caspase-3.Conclusions: MS could repair LIRI and reduce the release of oxidative stress, inflammatory cytokines, and cell apoptosis via the PI3K-AKT-NFκB signaling pathway, which may provide a novel and promising strategy for the treatment of LIRI.

Entities:  

Keywords:  Methane; anti-apoptosis; anti-inflammation; anti-oxidation; lung ischemia-reperfusion injury

Mesh:

Substances:

Year:  2020        PMID: 32079441     DOI: 10.1080/10799893.2020.1727925

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  5 in total

1.  Methane Inhalation Protects Against Lung Ischemia-Reperfusion Injury in Rats by Regulating Pulmonary Surfactant via the Nrf2 Pathway.

Authors:  Bing Zhang; Xiaojun Tian; Guangqi Li; Han Zhao; Xuan Wang; Yanwei Yin; Junmin Yu; Chao Meng
Journal:  Front Physiol       Date:  2021-05-12       Impact factor: 4.566

2.  Resveratrol against lung injury in an ischemia/reperfusion model of abdominal aortic rupture.

Authors:  Sedat Ozan Karakişi; Doğuş Hemşinli; Levent Tümkaya; Şaban Ergene; Tolga Mercantepe; Adnan Yılmaz
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2021-07-26       Impact factor: 0.332

3.  Dexmedetomidine Alleviates Lung Oxidative Stress Injury Induced by Ischemia-Reperfusion in Diabetic Rats via the Nrf2-Sulfiredoxin1 Pathway.

Authors:  Xuan Wang; Bing Zhang; Guangqi Li; Han Zhao; Xiaojun Tian; Junmin Yu; Yanwei Yin; Chao Meng
Journal:  Biomed Res Int       Date:  2022-02-24       Impact factor: 3.411

4.  Lidocaine attenuates hypoxia/reoxygenation‑induced inflammation, apoptosis and ferroptosis in lung epithelial cells by regulating the p38 MAPK pathway.

Authors:  Xiaojun Ma; Weihua Yan; Na He
Journal:  Mol Med Rep       Date:  2022-03-04       Impact factor: 2.952

5.  N6-methyladenosine reader YTH N6-methyladenosine RNA binding protein 3 or insulin like growth factor 2 mRNA binding protein 2 knockdown protects human bronchial epithelial cells from hypoxia/reoxygenation injury by inactivating p38 MAPK, AKT, ERK1/2, and NF-κB pathways.

Authors:  Kun Xiao; Pengfei Liu; Peng Yan; Yanxin Liu; Licheng Song; Yuhong Liu; Lixin Xie
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.